The Boston Scientific AcoArt Drug-Coated Balloon (REF ORC04250AG) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter designed for endovascular treatment of peripheral arterial disease. With a 4.0 mm balloon diameter and 250 mm working length, it is engineered to deliver a controlled antiproliferative drug dose to the vessel wall during inflation.
Key Features
- Drug coating: Paclitaxel-based antiproliferative coating intended to inhibit neointimal hyperplasia
- Balloon diameter: 4.0 mm
- Balloon length: 250 mm (long-lesion configuration)
- Catheter platform: Over-the-wire PTA balloon catheter
- Guidewire compatibility: 0.035" (per AcoArt Orchid platform)
- Recommended introducer sheath: Not specified in the located sources for this exact reference
- Rated burst pressure / nominal pressure: Not specified in the located sources for this exact reference
- Single-use, sterile (ethylene oxide): Per standard AcoArt Orchid labeling
Clinical Applications
- Percutaneous transluminal angioplasty of stenotic or occlusive lesions in peripheral arteries
- Long-segment lesion treatment in the superficial femoral and popliteal arteries where extended balloon length is advantageous
- Adjunctive post-dilatation following plain balloon angioplasty or atherectomy, where clinically indicated by the treating physician
Product Information
- Brand: Boston Scientific
- Product line: AcoArt Orchid Drug-Coated PTA Balloon Catheter
- Category: Peripheral Balloon Catheters
- REF / UPN: ORC04250AG
- Configuration code reference: 80 / 4.0 mm / 250 mm / 6 / 15
- Packaging: Single unit, sterile
- Regulatory status: Refer to the official manufacturer Instructions for Use and regional regulatory documentation